Document is current
Any future updates will be listed below
-
Authors
Davis, Timothy M. E. https://orcid.org/0000-0003-0749-7411
Davis, Wendy A.
Bringans, Scott D.
Lui, James K. C.
Lumbantobing, Tasha S. C.
Peters, Kirsten E.
Lipscombe, Richard J.
-
Funding
Funding for this research was provided by:
National Health and Medical Research Council (513781, 1042231)
- License Information
-
More Information
Article History
Received: 8 May 2024
Accepted: 11 June 2024
First Online: 10 October 2024
Declarations
:
: The FDS2 protocol was approved by the Human Research Ethics Committee of the Southern Metropolitan Area Health Service (reference 07/397) and all participants provided written informed consent to study procedures.
: Not applicable.
: Proteomics International and the University of Western Australia are beneficiaries of patent PCT/AU2011/001212 which relates to the biomarkers described in this manuscript. TMED, WAD, KEP and RJL are named as inventors of this patent. There are no other potential conflicts of interest relevant to this article.
